Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Capecitabine-induced cerebellar toxicity.

Daniel Renouf1, Sharlene Gill

  • 1Department of Medicine, University of British Columbia.

Clinical Colorectal Cancer
|June 27, 2006
PubMed
Summary

Capecitabine, an oral chemotherapy for colon cancer, can rarely cause neurotoxicity. This case highlights cerebellar ataxia as a potential side effect of capecitabine treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Clinical and molecular correlates of circulating tumor fraction in patients with metastatic pancreatic ductal adenocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma.

Nature communications·2026
Same author

Comparison of Lanreotide and Octreotide LAR Use and Outcomes for Gastrointestinal Neuroendocrine Tumors in British Columbia, Canada.

Cancer control : journal of the Moffitt Cancer Center·2026
Same author

Effects of a structured exercise program on motivational outcomes in patients with colon cancer.

Journal of the National Cancer Institute·2026
Same author

mTOR Inhibition in the Management of Recurrent Metastatic Solid Pseudopapillary Tumor of the Pancreas.

Pediatric blood & cancer·2025

Area of Science:

  • Oncology
  • Neuropharmacology

Background:

  • Capecitabine is a widely used oral prodrug of 5-fluorouracil.
  • It is a standard treatment for various adenocarcinomas, including colorectal cancer.

Observation:

  • Neurotoxicity is an uncommon but recognized adverse effect of capecitabine.
  • This report details a specific instance of neurological impairment linked to the drug.

Findings:

  • The patient developed cerebellar ataxia, a condition affecting coordination and balance.
  • This neurological complication was directly attributed to capecitabine therapy.

Implications:

  • Highlights the importance of monitoring for neurological side effects during capecitabine treatment.
  • Contributes to the understanding of capecitabine-induced neurotoxicity.
  • Informs clinical practice regarding patient selection and adverse event management.

Related Experiment Videos